TB-500 Fragmented (Short Chain)
Short-chain thymosin beta-4 fragment studied in actin-binding and tissue-remodeling research.
Short-chain thymosin beta-4 fragment studied in actin-binding and tissue-remodeling research.
The primary literature on this compound includes Goldstein et al., Ann N Y Acad Sci (2012). The references below link directly to the published record.
Every lot is synthesized in the USA, verified by HPLC, and ships with its Certificate of Analysis. It is supplied strictly for laboratory research use.
Research use only. Everything on this page describes laboratory research. This compound is supplied strictly for in-vitro research use; it is not approved by the FDA for human or veterinary use, and nothing here is a protocol or a recommendation.
Researchers also ordered
- BPC-15715-amino-acid synthetic pentadecapeptide derived from body-protection compound. Tissue-repair research peptide.
- GHK-CuCopper tripeptide-1. Studied in extracellular-matrix and fibroblast research.
- KPVC-terminal α-MSH tripeptide studied in inflammation and gut-mucosal research.
- LL-3737-residue human cathelicidin antimicrobial peptide studied in innate-immunity and wound-healing research.